Stay updated on Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No substantive changes to the study record are evident; the version history shows the initial entry with the same details and the page layout remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:18:07.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    - Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    13%
    Check dated 2025-10-06T05:56:35.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.3%
    Check dated 2025-09-29T03:14:00.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. No other content changes are detected on the page.
    Difference
    0.3%
    Check dated 2025-09-14T19:58:16.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-07T16:58:03.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms and the previous revision number have been removed.
    Difference
    4%
    Check dated 2025-08-31T12:08:58.000Z thumbnail image

Stay in the know with updates to Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.